Please login to the form below

Not currently logged in
Email:
Password:

market data

This page shows the latest market data news and features for those working in and with pharma, biotech and healthcare.

BMS eyes approval for second Opdivo combo in kidney cancer

BMS eyes approval for second Opdivo combo in kidney cancer

Detailed results presented at ESMO 2020 virtual congress. Bristol Myers Squibb has reported positive data for a combination of its PD-L1 inhibitor Opdivo with Exelixis’ Cabometyx in renal cell carcinoma ... data in this market.

Latest news

More from news
Approximately 1 fully matching, plus 129 partially matching documents found.

Latest Intelligence

  • Exploiting the value of data in pharma Exploiting the value of data in pharma

    A shift towards sharing data and collaboration with others may offer a further step change in lead time to market. ... Predictive analytics can also help reduce the need for physical trials in order to increase efficiency and time to market by making use

  • Creativity in storytelling: why pharma must invest more in creativity Creativity in storytelling: why pharma must invest more in creativity

    It sounds like a vote winner. There’s a growing suspicion that pharma’s investment in ‘brand’ is declining, with modern-day powerhouses like data, tech and market access all stealing ... In the rush to get messages to market, we must not allow

  • Pharmaceutical innovation in the APAC region Pharmaceutical innovation in the APAC region

    The following fresh perspective on innovation in the APAC pharma market is excerpted from a data-driven analysis that ranked companies on their degree of innovation, using a methodology expressly developed ... We then grouped the individual data

  • Patient journey mapping: exploring the clinical and the emotional journey Patient journey mapping: exploring the clinical and the emotional journey

    Immersing yourself in existing information, such as previous market research or exploring the disease area on social media platforms supports an initial data immersion exercise that can feed into a bespoke ... The data immersion and bespoke market

  • The evolution of real-world studies The evolution of real-world studies

    Pfizer brought Ibrance to market using data from randomised controlled trials (RCTs) in women, before supplementing that evidence with real- world data (RWD) in men to expand the label. ... Ibrance gained a new approval based on data from EHRs and other

More from intelligence
Approximately 1 fully matching, plus 37 partially matching documents found.

Latest appointments

  • Future Thinking appoints Mohamed Muhsin as UK pharma head Future Thinking appoints Mohamed Muhsin as UK pharma head

    Muhsin joins from QuintilesIMS Health, where he was therapy lead, oncology and prior to that he was a senior market analyst at Roche. ... Both Muhsin and Bonrepaux-Caux will be focusing on expanding Future Thinking’s global footprint, technical

  • LaingBuisson names chairman and CEO LaingBuisson names chairman and CEO

    Former Health Secretary Stephen Dorrell and Henry Elphick join. LaingBuisson, a UK healthcare market intelligence provider, has named Stephen Dorrell and Henry Elphick as its chairman and chief executive officer, respectively. ... Elphick said:

  • Natasha Giordano joins PLx Pharma Natasha Giordano joins PLx Pharma

    I look forward to building on the compelling clinical data and initial market access work the PLx management team has begun and to successfully launching PL2200 Aspirin into the U.S. ... market in 2017.” .

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 58 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...

Infographics